A Case Study of FDA Practices and Its Influence on Regulatory and Reimbursement Decisions for Darunavir

Authors :: E. Rubinstein
D. Liden
R. Jao
J. Rubinstein
H. Satyarthi
A. Jaksa
Source :: Value in Health. 16(7)
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: business.industry
Health Policy
medicine
Public Health, Environmental and Occupational Health
Accounting
Public relations
business
Darunavir
Reimbursement
medicine.drug

Full Text Access

Tools